Tanja Ouimet, PhD
Executive Director
Molecular neuroscientist with more than 25 years of experience spanning discovery, preclinical and clinical development, Tanja brings a strong combination of scientific expertise, operational leadership, and strategic vision. She has extensive experience across CRO operations, clinical development strategy, and executive management, supporting biotech and pharma companies at key value-inflection stages.
Before becoming Executive Director of ILife Consulting, Tanja served as Business & Strategy Director, where she played a central role in shaping the company’s positioning, strengthening client partnerships, and supporting the expansion of its clinical development and innovation services, notably following ILife Consulting’s acquisition by Comac Medical Group.
Her current responsibilities include:
-
Defining and executing ILife Consulting’s strategic vision
-
Overseeing clinical development strategy and high-value CRO support
-
Strengthening client partnerships and international growth
-
Leading teams across complex early-phase and innovation-driven programs
Experience
-
Drug design and development
-
International Phase I/II clinical development programs
-
CRO operations and complex outsourcing models
-
Clinical development strategy and execution
-
Executive leadership and strategic partnerships